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I N T R O D U C T I O N
Cardiac pacemaker activity is tightly regulated by the 
autonomic  nervous  system.  The  sympathetic  nervous 
system enhances heart rate and contractility, whereas the 
parasympathetic (vagal) inputs slow pacemaking. The 
dominant pacemaker region of the heart, the sinoatrial 
node (SAN), is innervated by a rich and complex net-
work of vagal nerve endings (Pauza et al., 1999, 2000). 
Parasympathetic regulation of SAN pacemaker activity is 
initiated when vagally released acetylcholine (ACh) binds 
to muscarinic M2 receptors, which promotes dissocia-
tion of  subunit complexes, leading to direct opening 
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Abbreviations used in this paper: ACh, acetylcholine; bpm, beats per 
minute; ECG, electrocardiogram; Girk, G-protein–gated inwardly rectify-
ing K
+ channel; HRV, heart rate variability; ISO, isoproterenol; MDP, maxi-
mum diastolic potential; SAN, sinoatrial node.
of  the  G-protein–gated  inwardly  rectifying  K
+  channel 
(Girk/Kir) IKACh (Krapivinsky et al., 1995; Wickman et al., 
1999).  Activation  of  muscarinic  receptors  negatively 
regulates  other  ion  channels  involved  in  heart  auto-
maticity, such as hyperpolarization-activated f (hyper-
polarization-activated cyclic nucleotide–gated channel 
[HCN])-channels underlying the If current (DiFrancesco, 
2010) and L-type Ca
2+ channels (ICa,L; Petit-Jacques et al., 
1993; Zaza et al., 1996; Mangoni and Nargeot, 2008),   
as  well  as  ryanodine  receptor–mediated  Ca
2+  release 
(Lakatta et al., 2010). All of these ionic mechanisms are 
thus potentially involved in the cholinergic regulation 
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Parasympathetic regulation of sinoatrial node (SAN) pacemaker activity modulates multiple ion channels to tem-
per heart rate. The functional role of the G-protein–activated K
+ current (IKACh) in the control of SAN pacemaking 
and heart rate is not completely understood. We have investigated the functional consequences of loss of IKACh in 
cholinergic regulation of pacemaker activity of SAN cells and in heart rate control under physiological situations 
mimicking the fight or flight response. We used knockout mice with loss of function of the Girk4 (Kir3.4) gene 
(Girk4
/ mice), which codes for an integral subunit of the cardiac IKACh channel. SAN pacemaker cells from 
Girk4
/ mice completely lacked IKACh. Loss of IKACh strongly reduced cholinergic regulation of pacemaker activity 
of SAN cells and isolated intact hearts. Telemetric recordings of electrocardiograms of freely moving mice showed 
that heart rate measured over a 24-h recording period was moderately increased (10%) in Girk4
/ animals. 
Although the relative extent of heart rate regulation of Girk4
/ mice was similar to that of wild-type animals, re-
covery of resting heart rate after stress, physical exercise, or pharmacological -adrenergic stimulation of SAN 
pacemaking was significantly delayed in Girk4
/ animals. We conclude that IKACh plays a critical role in the kinetics 
of heart rate recovery to resting levels after sympathetic stimulation or after direct -adrenergic stimulation of 
pacemaker activity. Our study thus uncovers a novel role for IKACh in SAN physiology and heart rate regulation.
© 2013 Mesirca et al.  This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.rupress.org/terms). After six months it is available under a Creative 
Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as 
described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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orientation determination and to preserve tissue integrity. WT 
and Girk4
/ mice were dissected and placed immediately into 
4% paraformaldehyde for 20 min at room temperature, followed 
by soaking in 1× PBS for several hours. The tissue was suspended 
in  250  µl  of  2%  BSA  (Sigma-Aldrich),  500  µg/ml  digitonin 
(Sigma-Aldrich) containing an anti-HCN4 monoclonal antibody 
(1:100 rat, SHG 1E5; Santa Cruz Biotechnology, Inc.), anti-Girk4 
polyclonal antibody (1:100 goat, A-14; Santa Cruz Biotechnology, 
Inc.),  or  anti-Girk1  polyclonal  antibody  (1:100  rabbit,  H-145; 
Santa Cruz Biotechnology, Inc.), and 0.002% Na azide to prevent 
bacterial growth. Tissues were incubated for 66 h at room tem-
perature with very gentle shaking in a Lab-Tek II chamber slide 
(Thermo Fisher Scientific). The tissue was rinsed 5 × 500 µl (1× 
PBS) over a 5-h period at room temperature. The procedure was 
repeated  again,  but  this  time  the  tissue  was  incubated  with 
chicken anti–rat Alexa Fluor 647 (1:500; Molecular Probes), don-
key anti–goat Alexa Fluor 568 (1:500; Molecular Probes), and 
donkey anti–rabbit Alexa Fluor 488 secondaries (1:500; Molecular 
Probes). The tissue was placed in ProLong Gold (Invitrogen), 
and a portion of the right atrium was removed and discarded   
to simplify mounting of the sample. A glass coverslip was gently 
placed over the sample with the epicardial side face up. Images 
were taken with a confocal microscope (TCS LSI; Leica) at the 
Montpellier RIO Imaging facility of the Arnaud de Villeneuve 
Campus. Analysis of images was performed with the JaCoP plugin 
for ImageJ (National Institutes of Health; Bolte and Cordelières, 
2006). Appropriate threshold levels were manually adjusted, and 
the  Manders  coefficient  of  colocalization  between  HCN4  and 
Girk4, as well as between HCN4 and Girk1 was calculated using 
JaCoP software.
Isolation of SAN cells
SAN cells were isolated as described previously (Mangoni and 
Nargeot, 2001). WT and Girk4
/ mice were killed by cervical 
dislocation under general anesthesia consisting of 0.01 mg/g 
xylazine (2% Rompun; Bayer AG) and 0.1 mg/g ketamine (Imal-
gène;  Merial),  and  beating  hearts  were  quickly  removed.  The 
SAN region was excised in warmed (35°C) Tyrode’s solution con-
taining (in mM): 140.0 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.0 
HEPES-NaOH, and 5.5 d-glucose (adjusted to pH 7.4 with NaOH) 
and cut in tissue strips. Strips were then transferred into a low-
Ca
2+, low-Mg
2+ solution containing (in mM): 140.0 NaCl, 5.4 KCl, 
0.5 MgCl2, 0.2 CaCl2, 1.2 KH2PO4, 50.0 taurine, 5.5 d-glucose, 
1.0 mg/ml BSA, and 5.0 HEPES-NaOH (adjusted to pH 6.9 with 
NaOH). The tissue was enzymatically digested by adding 229 U/ml 
collagenase  type  II  (Worthington  Biochemical  Corporation), 
1.9 U/ml elastase (Boehringer Mannheim), 0.9 U/ml protease 
(Sigma-Aldrich), 1 mg/ml BSA, and 200 µM CaCl2. Tissue diges-
tion was performed for a variable time of 9–13 min at 35°C with 
manual  agitation  using  a  flame-forged  Pasteur  pipette.  Tissue 
strips were then washed and transferred into a medium contain-
ing (in mM): 70.0 l-glutamic acid, 20.0 KCl, 80.0 KOH, 10.0 (±)
D--OH-butyric acid, 10.0 KH2PO4, 10.0 taurine, 1 mg/ml BSA, 
and 10.0 HEPES-KOH, pH 7.4 with KOH. SAN cells were manu-
ally dissociated in KB solution at 35°C for 10 min. Cellular auto-
maticity was recovered by readapting the cells to physiological 
extracellular Na
+ and Ca
2+ concentrations by adding aliquots of 
solutions containing (in mM): 10.0 NaCl, 1.8 CaCl2, and, sub-
sequently, normal Tyrode’s solution containing 1 mg/ml BSA. The 
final storage solution contained (in mM): 100.0 NaCl, 35.0 KCl, 
1.3 CaCl2, 0.7 MgCl2, 14.0 l-glutamic acid, 2.0 (±)D--OH-butyric 
acid, 2.0 KH2PO4, 2.0 taurine, and 1.0 mg/ml BSA, pH 7.4. Cells 
were then stored at room temperature until use. All chemicals 
were obtained from Sigma-Aldrich, except for the (±)D--OH-
butyric acid, which was purchased from Fluka Chemika. For elec-
trophysiological recording, SAN cells in the storage solution were 
harvested in special custom-made recording plexiglass chambers 
of heart rate, but their relative importance is still a matter 
of debate (Mangoni and Nargeot, 2008).
IKACh  is  strongly  expressed  in  the  SAN,  atria,  and 
atrioventricular  node  (Giles  and  Noble,  1976;  Noma 
and  Trautwein,  1978;  Löffelholz  and  Pappano,  1985; 
DiFrancesco et al., 1989; Lomax et al., 2003). Neuronal 
and cardiac Girk channels are homo- and heterotetra-
meric complexes formed by subunits encoded by four 
genes named Girk1–4 (Kir3.1–4; Wickman and Clapham, 
1995).  The  heart  expresses  Girk1  and  Girk4  genes 
(Wickman et al., 1999; Dobrzynski et al., 2001), and car-
diac IKACh channels are complexes consisting of Girk1 
and Girk4 (Wickman et al., 1999). However, the Girk1 
subunit requires coexpression of another Girk subunit 
to be targeted at the cell membrane (Kennedy et al., 
1999). Consequently, ablation of Girk4 subunits in mice 
leads to a complete loss of IKACh current in atrial myo-
cytes (Wickman et al., 1998).
The heart rate of Girk4 knockout mice (Girk4
/) 
shows reduced variability and a diminished responsive-
ness to pharmacological stimulation of the baroreflex 
and adenosine receptors (Wickman et al., 1998). How-
ever, the physiological effects of Girk4 inactivation on 
the SAN IKACh and on the cholinergic regulation of SAN 
pacemaking have not been investigated. Here we show 
that Girk4 inactivation abolished SAN IKACh and reduced 
cholinergic regulation of pacemaker activity in isolated 
SAN cells and intact hearts. In Girk4
/ mice, IKACh was 
required for normal recovery of resting heart rate after 
stress, physical exercise, or direct pharmacological stim-
ulation of pacemaking via -adrenergic receptors. Our 
study analyzes the impact of IKACh loss of function in the 
cholinergic regulation of SAN pacemaking and uncov-
ers  a  previously  unexpected  role  for  this  channel  in 
heart rate regulation.
M A T E R I A L S   A N D   M E T H O D S
The investigation conforms to the European directives (86/609/
CEE) and the Guide for the Care and Use of Laboratory Animals 
published by the U.S. National Institutes of Health (NIH publica-
tion no. 85-23, revised 1996). The French Ministry of Agriculture 
and the local Ethical Committee of the University of Montpellier 
1 & 2 approved all procedures with animals.
Girk4
/ mouse strain
Before starting the study, we obtained experimental Girk4
/ ani-
mals by crossing mice from the original mutant colony (Wickman 
et  al.,  1998)  with  mice  of  C57B6/J  genetic  background  from 
Charles River in the free of specific pathogenic organisms (EOPS) 
animal facility of the Réseau d’Animalèrie de Montpellier (RAM) 
at the Institut de Génetique Humaine (Montpellier, France). We 
next backcrossed the offspring for 10 generations on C57B6/J 
mice before starting the study. Animals were given ad libitum   
access to food and drinking water and were maintained in a 12-h 
light–dark cycle (light, 8:30 a.m. to 8:30 p.m.).
Staining of SAN tissue and image analysis
We used isolated mouse atrio-nodal (SAN-atrium) preparations   
in which the right atrium remained intact with SAN to facilitate   Mesirca et al. 115
heart rate was assessed as the time to recovery (r) calculated by 
fitting experimental data according to the one-phase-decay equa-
tion: y = e
(k × t), where y is the heart rate value in beats per minute 
(bpm) at a given time, t is time, and k = 1/r.
Statistical analysis
Two-way ANOVA was used for comparisons between genotypes 
and multiple ACh concentrations. When needed, Sidak’s multiple 
comparisons test was performed. Unpaired Student’s t test was used 
in all other analysis. Data are represented as the mean ± the SEM. 
Analysis was performed using Prism 6.0 (GraphPad Software).
Online supplemental material
The supplemental text describes the mRNA extraction and RT-PCR 
protocol. Fig. S1 shows the expression and distribution of Girk 
subunits in different mouse tissues by RT-PCR. Fig. S2 shows the 
heart rate variation in Girk4
/ mice after administration of atro-
pine, propranolol, and atropine plus propranolol. Fig. S3 shows 
the recovery of heart rate in Girk4
/ mice after treadmill test or 
intraperitoneal injection of atropine. Table S1 shows the action 
potential parameters in WT and Girk4
/ SAN cells before and 
after perfusion of 0.003, 0.01, and 0.05 µM ACh. Online supple-
mental material is available at http://www.jgp.org/cgi/content/
full/jgp.201310996/DC1.
R E S U L T S
Expression of Girk4 in mouse SAN
Atrial myocardium expresses Girk1 and Girk4 subunits. 
Loss of Girk4 abolishes IKACh single channel openings 
in cell-attached and inside-out patches of atrial cells of 
Girk4
/ mice (Wickman et al., 1998). We thus studied 
the distribution of Girk4 immunoreactivity in the intact 
SAN connected to the right atrium by macro-confocal 
microscopy. To define unambiguously the position of 
the SAN territory, as well as SAN pacemaker cells within 
the intact SAN-atrium preparation in WT and Girk4
/ 
hearts, we used anti-HCN4 immunoreactivity as a specific 
marker of spontaneously active SAN cells (Yamamoto   
et al., 2006; Christoffels et al., 2010). Staining of the in-
tact SAN showed that HCN4-positive pacemaker cells 
were present in the cranial pole of the SAN, close to its 
boundary with the crista terminalis, and that their distri-
bution was particularly dense in the region of dominant 
pacemaking identified by Verheijck et al. (2001; Fig. 1 
A, left). We did not observe differences in the abun-
dance, distribution, or location of HCN4-positive cells 
in Girk4
/ SAN preparations.
Girk4 immunoreactivity was present in both the SAN 
and right atrium (Fig. 1 A, middle). In the SAN region, 
Girk4 and HCN4 immunoreactivity largely overlapped 
(Fig.  1  A,  right).  Close-up  views  of  pacemaker  cells 
within the SAN showed that HCN4 immunoreactivity 
localized along the myocyte plasmalemma as reported 
previously in mouse SAN (Fig. 1 B, left; Herrmann et al.,   
2011). Individual HCN4-positive cells within the SAN re-
gion of WT hearts showed strong membrane-associated 
Girk4 and Girk1 immunoreactivity (Fig. 1 B, middle and 
right). Girk4 and Girk1 immunoreactivity overlapped 
with glass bottoms for proper cell attachment. The storage solu-
tion  was  continuously  rinsed  with  normal  Tyrode’s  solution 
warmed at 36°C before recording.
Patch-clamp recordings of mouse SAN cells
The basal extracellular Tyrode’s solution used in all recordings 
contained (in mM): 140.0 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.0 
HEPES-NaOH,  5.5  and  d-glucose  (adjusted  to  pH  7.4  with 
NaOH). IKACh and If were recorded using the standard whole-cell 
configuration. Patch-clamp electrodes had a resistance of 4–5 M 
when filled with an intracellular solution containing (in mM): 
130.0 K
+-aspartate; 10.0 NaCl; 2.0 ATP-Na
+ salt, 6.6 creatine phos-
phate, 0.1 GTP-Mg
2+, 0.04 CaCl2 (pCa = 7.0), and 10.0 HEPES-
KOH  (adjusted  to  pH  7.2  with  KOH).  For  recording  ICa,L, 
K
+-aspartate  in  the  intracellular  solution  was  replaced  with  an 
equal  amount  of  CsCl.  The  extracellular  solution  contained   
(in mM) 130 TEA-Cl, 2 CaCl2, 1 MgCl2, 10 4-amino-pyridine, and 
25 HEPES (adjusted to pH 7.4 with TEA-OH). A correction of   
9.8 mV because of liquid junction potential was applied in ICa,L 
recordings (calculated with Patcher’s Power Tools; Wavemetrics). 
All experiments were performed at 36°C. Pacemaker activity of 
SAN cells was recorded under perforated patch conditions by 
adding 50 µM -escin to the pipette solution.
Isolated Langendorff perfused intact hearts
Excised hearts were quickly mounted on a Langendorff apparatus 
(Isolated heart system; EMKA Technologies) at a constant pres-
sure of 80 mm Hg with normal Tyrode’s solution. Perfused hearts 
were immersed in the water-jacked bath and maintained at 36°C. 
The electrocardiogram (ECG) was continuously recorded by 
Ag-AgCl electrodes positioned on the epicardial side of the right 
atrium close to the SAN area and near the apex. The heart rate 
was allowed to stabilize for at least 30 min before perfusion of 
ACh and/or isoproterenol (ISO).
Telemetric recordings of ECG and analysis
For telemetric ECG recording, adult male mice were anesthetized 
with 2% isoflurane. A midline incision was made on the back 
along the spine to insert a telemetric transmitter allowing simul-
taneous recording of ECG and home-cage activity (TA10EA-F20; 
Data  Sciences  International)  into  a  subcutaneous  pocket  with 
paired wire electrodes placed over the thorax (chest bipolar ECG 
lead). Local anesthesia was obtained with 1% lidocaine injected 
subcutaneously at the sites of electrodes and transmitter im-
plantation. To manage possible post-surgery pain, Advil (7 ml/l 
paracetamol and ibuprofen) was added to the drinking water for 
4 d after implantation. Experiments were initiated at least 8 d 
after recovery from surgical implantation. Mice were housed in 
individual cages with ad libitum access to food and water and 
were exposed to standard 12-h light–dark cycles in a thermo-
statically controlled room. ECG signals were recorded using a 
telemetry receiver and an analogue to digital conversion data 
acquisition system for display and analysis by Dataquest A.R.T.TM 
software (Data Sciences International). Heart rates were deter-
mined from inter-beat (RR) intervals of the ECG. Mean heart rate 
values were obtained in each mouse for an overall 24-h period 
from 8:30 a.m. to 8:30 p.m. and analyzed as previously described 
by Alig et al. (2009). Heart rate variability (HRV) spectra of WT 
and Girk4
/ mice were analyzed from RR intervals according to 
Wickman et al. (1998). For drug administration or physical exer-
cise experiments, mean heart rate values were calculated in each 
mouse by analyzing 5-min periods. ECG parameters were mea-
sured with ECG Auto 1.5.7 software.
Swimming tests were performed by using homemade plexiglass 
boxes of 15 × 32 cm and of 13 cm in height filled with prewarmed 
water (32°C) 9 cm deep. For exercise experiments, we used a two-
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of Girk isoforms in cardiac and neuronal tissues, we   
purified mRNA from tissue samples of the SAN, right 
atrium, left ventricle, brain cortex, and cerebellum. Myo-
cardial tissues and the SAN expressed only Girk4 and 
Girk1 mRNA, whereas Girk2 and Girk3 were expressed 
in the cortex and cerebellum, respectively. We did not 
find Girk4 mRNA in SAN preparations of Girk4
/ 
mice (Fig. S1).
Pacemaker cells from Girk4
/ mice lack IKACh
We studied the expression of IKACh current in WT and 
Girk4
/ SAN cells (Fig. 2). We recorded IKACh by hold-
ing the membrane voltage at 35 mV and then perfus-
ing ACh for 20 s before returning to control solution 
(Fig. 2 A). In WT cells, ACh dose-dependently increased 
the IKACh current (Fig. 2, A and B). At concentrations of 
ACh >1 µM, the peak IKACh current decreased as the re-
sult  of  channel  desensitization  (Fig.  2  B;  Boyett  and 
Roberts, 1987; Zang et al., 1993). We failed to observe 
detectable residual IKACh in Girk4
/ SAN cells in the 
full range of ACh concentrations tested (Fig. 2, A and B). 
We also did not observe IKACh in atrial cells that were iso-
lated in parallel from the same Girk4
/ hearts used for 
recordings of SAN cells (not depicted). We conclude that 
inactivation of Girk4 channels abolished IKACh in mouse 
SAN pacemaker cells.
We also tested whether inactivation of Girk4 affected 
the density of If and ICa,L, which are potentially involved 
in parasympathetic regulation of heart rate (Mangoni 
and Nargeot, 2008). We did not find significant differ-
ence in the peak densities, activation, and kinetics of If 
(Fig. 3 A) or ICa,L (Fig. 3 B) between WT and in Girk4
/ 
SAN cells.
Loss of IKACh in Girk4
/ mice reduces cholinergic 
regulation of pacemaker activity in SAN cells  
and in isolated intact hearts
To investigate how the loss of IKACh affects the negative 
chronotropic effect of ACh on pacemaker activity, we re-
corded automaticity of SAN cells from WT and Girk4
/ 
mice (Fig. 4). To mimic moderate basal activation of the 
-adrenergic  signaling  pathway,  we  added  2  nM  ISO 
to  the  Tyrode’s  solution,  a  concentration  inducing  a   
submaximal  positive  chronotropic  effect  on  SAN  cell 
pacemaking (Alig et al., 2009). Under these conditions, 
the  basal  pacing  rate,  action  potential  threshold  and   
duration, and maximum diastolic potential (MDP) of 
WT and Girk4
/ SAN cells did not significantly differ 
(Table S1). In WT cells, ACh dose-dependently slowed 
pacemaker  activity,  with  effects  evident  at  0.003  µM   
and maximal at 0.05 µM (Fig. 4 A). At 0.003 µM, ACh-
induced pacemaker rate reduction did not differ signifi-
cantly between WT and Girk4
/ SAN cells, even though 
we observed a trend toward an increase in WT (17%   
in WT and 10% in Girk4
/ SAN cells; Fig. 4, A–C; and 
Table S1). At 0.01 µM ACh, the absence of Girk4 resulted 
with HCN4 in the field of view in WT SAN (Manders 
coefficient of 0.46 ± 0.04 for Girk4 and 0.5 ± 0.05 [n = 5] 
for Girk1 immunoreactivity). In contrast, Girk4
/ SAN 
preparations displayed HCN4-positive and Girk4-nega-
tive cells (Manders coefficient of 0.004 ± 0.02; n = 3). In 
agreement with the notion that Girk1 is not targeted   
to the membrane in the absence of Girk4, we failed to 
observe membrane-bound Girk1 immunoreactivity in 
Girk4
/ SAN cells (Fig. 1 B, right).
Because it is known that the SAN gene expression 
profile may include ion channel genes that are not ex-
pressed in atria or ventricles (Marionneau et al., 2005), 
we tested the potential expression and distribution of 
mRNA coding for Girk2 or Girk3 subunits in the mouse 
SAN by RT-PCR (Fig. S1 A). To compare the expression 
Figure 1.  Distribution and localization of anti-Girk immunoreac-
tivity in isolated mouse atrio-sinus preparations. (A) Representa-
tive images of n = 3 isolated SAN right atrium (RA) preparations 
(endocardial side) double stained with HCN4 and Girk4 antibodies. 
CT, crista terminalis; IVC and SVC, inferior and superior vena 
cava, respectively. (B) Close-up views of pacemaker cells within   
the SAN stained with HCN4, Girk4, or Girk1 antibodies. Indi-
vidual HCN4-positive cells within the SAN region of WT hearts 
showed strong membrane-associated Girk4 and Girk1 immuno-
reactivity (top). Girk4
/ SAN cells displayed HCN4-positive and 
Girk4-negative staining and no membrane-bound Girk1 (bottom).   
Bars, 10 µm.  Mesirca et al. 117
potential threshold, velocity, duration, or MDP of WT 
and Girk4
/ SAN cells (Table S1).
We next investigated the impact of IKACh ablation on 
the  negative  chronotropic  effect  of  ACh  in  isolated   
Langendorff-perfused intact hearts (Fig. 5). At concen-
trations < 0.3 µM, ACh similarly slowed the beating rate 
of WT and Girk4
/ hearts (Fig. 5, A and B). Increasing 
ACh  concentrations  up  to  10  µM  dose-dependently   
reduced beating rates of WT hearts (53% decrease in 
beating rate). In contrast, the negative chronotropic re-
sponse of Girk4
/ hearts to ACh at doses ranging from 
0.3 to 10 µM did not significantly increase further (19%), 
indicating that loss of IKACh induced saturation of the 
maximal negative chronotropic response at moderate 
in an obvious difference in rate reduction, from 71% in 
WT to 36% in Girk4
/ SAN cells (Fig. 4, A–C). Finally, 
ACh  induced  a  strong  (52%)  negative  chronotropic   
effect on Girk4
/ SAN cells at 0.05 µM, but contrary 
to WT cells, we never observed cessation of pacemaker   
activity in knockout cells at this concentration. MDP was 
significant hyperpolarized in WT SAN cells challenged 
with 0.05 µM ACh (Fig. 4 A and Fig. S1 B); membrane 
hyperpolarization persisted for 4 s before settling to a 
stable membrane voltage that did not significantly differ 
from that recorded before ACh superfusion (Fig. S1 B). 
ACh reduced the slope of the diastolic depolarization 
in WT and Girk4
/ SAN cells at all concentrations 
>0.01 µM (Table S1). ACh did not affect the action 
Figure  2.  Inactivation  of  Girk4  chan-
nels  ablates  IKACh  in  mouse  SAN  cells. 
(A)  Sample  traces  of  IKACh  current  in 
WT and Girk4
/ SAN cells. IKACh was 
activated by ACh in WT and Girk4
/ 
SAN cells. Arrows indicate the period of 
time for which ACh was added. (B) IKACh 
density at different ACh concentrations 
in  SAN  cells  from  WT  (0.003–10  µM; 
n = 4–16; closed circles) and Girk4
/ 
(0.003–10 µM; n = 3–13; open circles) 
mice. Error bars represent SEM. Statisti-
cal symbols: *, P < 0.05; and **, P < 0.01.
Figure 3.  Loss of IKACh in Girk4
/ mice did not affect functional expression of If and ICa,L. (A, left) Isochronal current to voltage curves 
for If in SAN cells from WT (n = 8; closed circles) and Girk4
/ (n = 10; open circles) mice. (right) Representative voltage-clamp record-
ings of If in isolated WT and Girk4
/ SAN cells. Applying hyperpolarizing voltage steps from a holding potential of 30 mV evoked If 
current. (B, left) Isochronal current to voltage curves of ICa,L in SAN cells from WT (n = 12; closed circles) and Girk4
/ (n = 9; open 
circles). (right) Sample traces of ICa,L in SAN cells from WT and Girk4
/ mice. Recordings were obtained by applying depolarizing volt-
age steps from a holding potential of 55 mV. Voltage-clamp protocols are shown below the traces, and the dashed lines indicate the 
zero voltage. Error bars represent SEM.118 IKACh ablation in sinoatrial node physiology
reduced in our Girk4
/ mice (Fig. 6, D and E; Wickman 
et al., 1998).
We recorded significantly higher heart rates in Girk4
/ 
mice in comparison with that of WT mice over a typi-
cal 24-h recording period (Fig. 6, F–J). Indeed, the dis-
tribution of heart rates of Girk4
/ mice was shifted 
to higher values (Fig. 6 F), and elevated heart rate in 
Girk4
/ mice was present at all degrees of spontane-
ous activity in the home cage (Fig. 6 G). The rate to activ-
ity relationship of Girk4
/ mice was similar to that of 
WT counterparts (Fig. 6 G), indicating that mild tachy-
cardia was caused by a reduced cholinergic response 
of SAN pacemaker activity rather than by an elevation 
of sympathetic tone in knockout animals. In agreement 
with this hypothesis, we observed similar increases in 
heart rate for any increase in spontaneous activity in 
WT and Girk4
/ mice (Fig. 6 H). Also, the difference 
between averaged maximal and minimal daily heart 
rates was similar in WT and Girk4
/ mice, demonstrat-
ing that, in spite of reduced HRV, the relative degree of   
doses of ACh. Collectively, these observations indicate 
that IKACh is an important determinant of cholinergic 
regulation of pacemaker activity in both isolated SAN 
cells and intact Langendorff-perfused hearts.
Heart rate regulation in Girk4
/ mice
To investigate the consequences of IKACh ablation on 
heart rate regulation in vivo, we recorded ECGs of freely 
moving WT and Girk4
/ mice by telemetry (Fig. 6 A). 
WT and Girk4
/ mice had similar spontaneous activi-
ties in the home cage (not depicted; in agreement with 
previous observations), indicating that Girk4 inactiva-
tion does not affect locomotor activity (Wickman et al., 
2000).  Although  there  was  normal  high-frequency 
variation of heart rate (HRV) in WT, HRV in Girk4
/ 
mice varied on a slower time scale (Fig. 6, B and C). 
Consis  tent with previous observations in Girk4
/ mice 
of pure 129Sv/J or mixed (129Sv/J/C57B6/J) genetic 
back  grounds (Wickman et al., 1998), both the high- 
and low-frequency spectral components of HRV were 
Figure 4.  Cholinergic regulation of pacemaker activity in WT and Girk4
/ SAN cells. (A) Examples of spontaneous action potentials 
recorded in SAN cells from WT and Girk4
/ hearts in control conditions (black traces) and after perfusion of ACh (gray traces) at the 
indicated doses. (B) Histograms of pacing rate of WT (closed bars) and Girk4
/ (open bars) SAN cells in control conditions (WT n = 6; 
Girk4
/ n = 6) and after perfusion of 0.003 (WT n = 5; Girk4
/ n = 7), 0.01 (WT n = 18; Girk4
/ n = 10), and 0.05 µM ACh (WT n = 5; 
Girk4
/ n = 7). (C) Dose–response relation of the percentage of slowing of pacemaker rate by ACh in WT (closed circles) and Girk4
/ 
(open circles) SAN cells. At 0.01 µM ACh, inactivation of Girk4 channels significantly reduced the negative chronotropic effect from 
67% in WT to 26% in Girk4
/ SAN cells. At 0.05 µM ACh, pacing was absent in WT, whereas it was reduced to 50% in Girk4
/ SAN 
cells. Error bars represent SEM. Statistical symbols: **, P < 0.01; and ***, P < 0.001.  Mesirca et al. 119
Next, we studied the effects of IKACh loss in heart rate 
regulation under conditions of forced physical exercise. 
First, we recorded heart rate during a period of stress 
associated with physical activity (forced swim; Kirchhof 
et al., 2003; Harzheim et al., 2008). Heart rate was mea-
sured during a fixed exercise period, consisting of 5 min 
of swimming followed by 4 h of rest to recover basal 
heart rate in the home cage (Kirchhof et al., 2003). Both 
WT and Girk4
/ mice reached similar maximal heart 
rates during the 5-min swimming period (Fig. 7 A). How-
ever, WT mice returned to resting heart rates more rap-
idly than Girk4
/ mice; heart rates of WT mice reached 
resting levels after 55 min (r = 33 ± 7 min), whereas 
>100 min were necessary for Girk4
/ mice to recover 
resting heart rates (r = 58 ± 5 min; Fig. 7 A, inset). Simi-
larly, on treadmill tests (Herrmann et al., 2007), WT 
and Girk4
/ mice ran for 5 min followed by a 4-h rest-
ing period. Similar to what was observed during the 
swimming test, knockout mice exhibited longer time to 
recovery of resting heart rates than their WT counter-
parts (r = 17 ± 2 min in n = 6 WT and r = 41 ± 11 min 
in n = 4 Girk4
/ mice; P < 0.05; Fig. S3 A).
regulation of daily heart rate was conserved after IKACh 
ablation (Fig. 6, I and J).
To further test whether elevated heart rate in knock-
out mice was caused by loss of function of IKACh in the 
SAN, we measured heart rates after systemic adminis-
tration (intraperitoneally) of atropine or propranolol. 
We recorded similar heart rates in WT and Girk4
/ 
mice after inhibition of vagal input by administration   
of atropine, an observation which showed that sympa-
thetic tone was not altered in Girk4
/ mice (Table 1, A 
and B, and Fig. S2). Similar heart rates were also ob-
served after blockade of sympathetic input by propran-
olol or combined injection of these two drugs, indicating 
that vagal tone did not differ between WT and Girk4
/ 
mice (Table 1, A and B, and Fig. S2). These observations 
indicate  that  increased  heart  rates  of  Girk4
/  mice 
could not be ascribed to dysfunction of the sympathetic 
or  vagal  branches  of  the  autonomic  nervous  system 
(Fig. S2). Furthermore, we did not observe significant 
differences in other parameters of the ECG waveform 
in  comparing  Girk4
/  mice  with  their  WT  counter-
parts (Table 1, A and B, and Fig. S2).
Figure 5.  Negative chronotropic response to ACh of isolated WT and Girk4
/ hearts. (A and B) Dose–response relations expressed as 
absolute values (bpm; A) or percentage of heart rate (HR) slowing (B) by ACh in n = 7 WT (closed bars and circles) and n = 8 Girk4
/ 
Langendorff-perfused hearts (open bars and circles). (C) Sample traces of ECGs recorded from Langendorff-perfused hearts at baseline 
and after 0.3 µM ACh in WT and Girk4
/. Note that reduction in heart rate was more pronounced in WT than in Girk4
/ hearts. Error 
bars represent SEM. Statistical symbols: *, P < 0.05.120 IKACh ablation in sinoatrial node physiology
We then investigated whether the delay in basal heart 
rate recovery observed in Girk4
/ mice could also be 
recorded in isolated hearts (Fig. 8 A). Because it was 
possible  that  -adrenergic  tone  could  persist,  we  re-
corded the time course of the ACh-mediated negative 
chronotropic effect under persistent -adrenergic acti-
vation (Fig. 8 B). Our assumption was that this condi-
tion could mimic in vivo heart rate reduction by strong 
vagal activation in the presence of a persistent back-
ground -adrenergic activation (Fig. 8 B). We paced 
isolated Langendorff-perfused WT and Girk4
/ hearts 
with 0.1 µM ISO for 5 min to allow the agonist effect   
to reach steady-state (Fig. 8 A). We then switched the 
perfusate to a test solution lacking ISO but containing 
To test whether the difference in heart rate recovery 
could  be  reproduced  by  direct  pharmacological  acti-
vation  of  -adrenergic  receptors,  we  investigated  the 
responsiveness of heart rate in vivo after systemic ad-
ministration of 0.1 mg/kg ISO. Similar to what we ob-
served  with  physical  activity,  WT  and  Girk4
/  mice 
reached comparable maximal heart rates after injection 
of ISO. Again, recovery of basal heart rate after ISO in-
jection was longer in Girk4
/ than in WT mice (Fig. 7 B). 
In contrast, injection of atropine, which elevates heart 
rate  by  blocking  muscarinic  receptors,  similarly  in-
creased heart rates in WT and Girk4
/ mice, but the 
recovery of basal heart rate did not differ significantly 
in the two mouse strains (Fig. S3 B).
Figure 6.  Heart rate in Girk4
/ mice. (A) Sample traces of ECGs recorded in freely moving WT and Girk4
/ mice. (B and C) Dot 
plots of beat to beat variability (in bpm) of heart rate (HR) of WT (B) and Girk4
/ (C) mice for a 5-min ECG recording epoch. The 
dashed lines indicate the averaged heart rate. (D and E) Bar graphs showing averaged low-frequency (LF; D) and high-frequency (HF; E)   
power spectra of HRV in WT (n = 10) and Girk4
/ (n = 9) mice for recordings shown in B and C. (F) Histogram showing the distribu-
tion of normalized averaged heart rates in a 24-h period of telemetric ECG recordings in WT (n = 10; black line) and Girk4
/ (n = 9; 
gray line) mice. For a given mouse, individual heart rate values were calculated every 20 s over the 24-h recording and then normalized to 
the maximal heart rate recorded for the mouse to allow comparison between WT and Girk4
/ animals. Note that the two distributions 
have similar shapes, but that Girk4
/ heart rates are shifted toward higher values. (G) Relationship between heart rate and spontaneous 
home cage activity (rate to activity relationship) of WT (closed bars) and Girk4
/ mice (open bars). Activity values are defined as arbi-
trary units (A.U.) and have been binned in six intervals of increasing activity. Binning was adjusted to obtain maximal resolution of the 
heart rate to activity relationship. (H) Similarity in the range of heart rate regulation as a function of activity in WT and Girk4
/ mice. 
For each animal, the heart rate corresponding to bin 1 (lowest activity) was subtracted from the heart rate recorded at other degrees 
of activity. (I) Averaged heart rate measured over a 24-h recording in Girk4
/ (583 ± 11 bpm; n = 9; open bars) and WT mice (539 ± 
10 bpm; n = 10; closed bars; P < 0.05). (J) Range of heart rate regulation calculated from the differences between the maximum and 
minimum heart rate in each mouse recorded over the 24-h recording period. Error bars represent SEM. Statistical symbols: *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; and ****, P < 0.0001.  Mesirca et al. 121
under different physiological conditions is still a matter 
of debate (Mangoni and Nargeot, 2008; DiFrancesco, 
2010; Lakatta et al., 2010). In particular, the physiologi-
cal importance of IKACh in the autonomic regulation of 
SAN pacemaking is not completely understood. In atrial 
myocardium, IKACh plays an important role in regulating 
resting membrane potential and action potential repo-
larization (Kaibara et al., 1991; Lomax et al., 2003). IKACh 
activation  also  favors  atrial  reentry  and  triggering  of 
atrial fibrillation by rapid pacing in experimental mam-
mals (Cha et al., 2006) and mice (Kovoor et al., 2001). 
Selective block of IKACh prevents ACh-induced conduc-
tion block in the AV node, demonstrating that this 
current plays an important role in vagal regulation of 
atrioventricular conduction (Drici et al., 2000). Even   
if  Girk1  and  Girk4  subunits  are  relatively  poorly  ex-
pressed in ventricular tissue in comparison with atrium 
(Dobrzynski et al., 2001), IKACh can exert a direct nega-
tive inotropic effect in ventricular myocytes (McMorn   
et al., 1993), suggesting that this current also regulates 
the ventricular and Purkinje fiber action potentials in 
some species.
Here,  we  showed  that  genetic  inactivation  of  IKACh 
strongly diminishes the cholinergic regulation of SAN 
pacemaking and reduces the speed of recovery of rest-
ing heart rates after physiological tests mimicking the 
fight or flight response. The expression profile of Girk 
channel subunits in the mouse SAN is similar to that   
of the atria (Wickman et al., 1998). No mRNA coding 
for Girk2 or Girk3 subunits could be amplified in PCR 
0.3 µM ACh and observed the recovery of heart rate   
to  the  unstimulated  condition  before  ISO  perfusion 
(Fig. 8 A). Similarly to what we observed in freely mov-
ing mice, recovery of Girk4
/ hearts was significantly 
delayed in comparison with their WT counterparts (r = 
23 ± 10 s in n = 8 WT and r = 101 ± 27 s in n = 7 Girk4
/ 
mice; P < 0.05; Fig. 8 A, inset). We then studied the time 
course  of  heart  rate  change  upon  perfusion  of  ACh 
under continuous stimulation by ISO. Under these con-
ditions, ACh slowed pacing of ISO-stimulated WT and 
Girk4
/ hearts to a similar degree (54 ± 28 bpm and 
59 ± 19 bpm in WT and Girk4
/ hearts, respectively; 
P > 0.05), but the pacemaker rate of knockout hearts 
reached  steady-state  levels  after  a  significantly  slower 
time course (r = 24 ± 3 s in n = 8 WT and r = 84 ± 12 s 
in n = 6 Girk4
/ mice; P < 0.05; Fig. 8 B, inset). Collec-
tively, these observations indicate that the delay in heart 
rate recovery in Girk4
/ mice is a direct consequence 
of SAN IKACh ablation.
D I S C U S S I O N
We demonstrate that IKACh is a critical mechanism in-
volved in the muscarinic regulation of SAN pacemaker 
activity and heart rate regulation after the fight or flight 
response. Cardiac pacemaker activity is tightly regulated 
by the autonomic nervous system. Distinct ion chan-
nels or intracellular Ca
2+ handling mechanisms are 
potentially involved in the parasympathetic control of 
pacemaker activity and heart rate, but their importance 
TA B L E   1   A
ECG interval values
Conditions PR QT QRS QTc
ms ms ms ms
WTNaCl 38 ± 1 47 ± 2 11 ± 1 44 ± 2
Girk4
/
NaCl 36 ± 1 49 ± 2 11 ± 1 47 ± 2
WTAtrop 34 ± 1 43 ± 3 10 ± 1 45 ± 2
Girk4
/
Atrop 34 ± 1 44 ± 2 11 ± 1 46 ± 2
WTProp 40 ± 2 55 ± 2 10 ± 1 42 ± 1
Girk4
/
Prop 41 ± 1 51 ± 2 10 ± 1 45 ± 2
See legend below Table 1 B.
TA B L E   1   B
Statistical analysis of RR and PR ECG intervals
Conditions RR/PR
Girk4
/
NaCl WTAtrop Girk4
/
Atrop WTProp Girk4
/
Prop
WTNaCl NS/NS <0.05/NS <0.01/<0.05 <0.01/NS <0.001/NS
Girk4
/
NaCl NS/NS <0.05/NS <0.001/NS <0.001/<0.01
WTAtrop NS/NS <0.001/<0.01 <0.001/<0.001
Girk4
/
Atrop <0.001/<0.001 <0.001/<0.001
WTProp NS/NS
Atrop, atropine; Prop, propranolol. ECG interval values in WT and Girk4
/ mice under control conditions (intraperitoneal injection of NaCl) or after 
systemic administration of 0.5 mg/kg atropine or 5 mg/kg propranolol are shown.122 IKACh ablation in sinoatrial node physiology
IKACh loss of function strongly reduced the negative 
chronotropic effect of ACh in both isolated SAN cells 
and  intact  Langendorff-perfused  hearts.  The  pace-
maker activity of isolated SAN cells was more sensitive to 
ACh than that of intact hearts. This difference may re-
sult from the “pacemaker shift” phenomenon, in which 
perfusion of ACh shifts the dominant site of origin of 
the SAN impulse to groups of cells with lower sensitivity 
to ACh (Boyett et al., 2000). Remarkably, the maximal 
negative chronotropic effect induced by high doses of 
ACh (0.3–10 µM) in Girk4
/ hearts did not exceed 
20%, whereas WT hearts slowed pacemaking by 35–
53%. At relatively low agonist concentrations (<0.3 µM), 
the  ACh-induced  negative  chronotropic  effect  was 
similar between WT and Girk4
/ mice, but heart rate 
slowing was modest or moderate (5–10%). In this respect, 
it  has  been  proposed  that  the  muscarinic  regu  lation   
of  heart  rate  at  low  vagal  tone  or  ACh  concentration   
depends exclusively on If (DiFrancesco et al., 1989; Zaza 
et al., 1996; Yamada, 2002). It is thus possible that 
experiments  of  SAN  tissue  (Fig.  S1  A).  In  contrast, 
Girk4 immunoreactivity was widely distributed in the 
SAN, defined as the HCN4-positive region bordered by 
the caval veins, the crista terminalis, and the interatrial 
septum (Yamamoto et al., 2006). SAN cells expressing 
anti-HCN4  immunoreactivity  were  also  positive  for 
Girk4 and Girk1, with strong membrane-bound protein 
expression as described in larger mammals (Dobrzynski 
et al., 2001). We did not observe residual positive anti-
Girk4 immunoreactivity in individual SAN cells within 
the intact SAN of Girk4
/ hearts. Although SAN cells 
from knockout hearts exhibited Girk1 immunoreactiv-
ity, staining did not appear to be associated with cell 
membranes. This observation is consistent with the notion 
that Girk1 subunits cannot form functional channels 
in the absence of Girk4 (Kennedy et al., 1999) and that 
atrial myocytes isolated from Girk4
/ mice do not have 
residual IKACh channel activity (Wickman et al., 1998). 
Accordingly, we failed to observe residual IKACh in SAN 
cells of Girk4
/ mice (Fig. 2).
Figure 7.  Recovery of resting heart rate in Girk4
/ mice. (A and B) After swimming test (A) and upon intraperitoneal injection of 
ISO (B). (A, left) Swimming test (5 min) was used to monitor heart rate (HR) during physical exercise of WT (n = 5; closed circles) 
and Girk4
/ (n = 6; open circles) mice. Continuous lines represent fitting of experimental data points to calculate r of recovery. 
Dashed lines represent the basal heart rate before swimming test in WT (black) and Girk4
/ (gray) mice. Averaged r for WT and 
Girk4
/ mice is reported in the insets. (right) Samples ECG traces from WT and Girk4
/ mice at rest (before swimming) and 
85 min after swimming. Note that at 85 min in Girk4
/ but not in WT mice, heart rate was still higher than the heart rate in the 
resting condition. (B, left) Basal heart rate recovery after direct activation of -adrenergic receptors by 0.1 mg/kg ISO in WT (n = 15; 
closed circles) and Girk4
/ (n = 11; open circles) mice. Dashed lines represent the basal heart rate before injection of ISO in WT 
(black) and Girk4
/ (gray) mice. Averaged r for WT and Girk4
/ mice is reported in the inset. (right) Samples ECG traces from 
WT and Girk4
/ mice under basal conditions and 60 min after ISO injection. At min 60 in Girk4
/ mice but not in WT, heart rate 
was still higher than the basal heart rate. Error bars represent SEM. Statistical symbols: *, P < 0.05.  Mesirca et al. 123
release (Lyashkov et al., 2009; van Borren et al., 2010) 
can sustain a degree of vagal control of pacemaker activ-
ity in vivo.
Our experimental data indicate that moderate tachy-
cardia is caused by a loss of tonic inhibition of SAN 
pacemaking by IKACh rather than by sympathetic over-
drive in knockout mice. First, the rate to activity rela-
tionships in WT and Girk4
/ mice were similar, with 
the degree of heart rate regulation preserved after in-
creasing activity. This observation shows that Girk4
/ 
mice have a normal range of heart rate control and 
compliance of the autonomic nervous system. In this 
respect,  the  phenotype  of  Girk4
/  mice  clearly  dif-
fered  from  that  of  mice  lacking  voltage-dependent 
Cav2.2 Ca
2+ channels, which show elevated heart rate as 
the  result  of  increased  sympathetic  tone  and  have  a 
strongly reduced range of cardiovascular control (Ino 
et  al.,  2001).  Second,  we  recorded  similar  maximal 
heart rates and time to recovery of basal rate upon in-
jection of atropine in WT and Girk4
/ mice, although 
negative regulation of If current by ACh was responsi-
ble, at least in part, for the chronotropic effect observed 
at low agonist doses observed in our experiments.
The mean daily heart rate of Girk4
/ mice was signifi-
cantly faster than that of WT mice, irrespective of the 
relative level of spontaneous activity. Resting heart rates 
recorded before drug administration or physical tests 
also showed a trend to elevation in knockout animals.   
It is important to note that in spite of increased basal 
heart rates and reduced HRV, the relative degree of rate 
regulation  was  similar  in  WT  and  Girk4
/  mice.  In 
other words, despite the fact that Girk4
/ mice cannot 
adjust their heart rate on short time scales (Wickman   
et al., 1998), they can still exhibit fluctuations compa-
rable with those measured in WT controls. This obser-
vation  suggests  that  other  mechanisms  involved  in 
autonomic regulation of SAN pacemaking, such as cAMP- 
dependent regulation of f-channels (DiFrancesco, 1993),   
ICa,L (Petit-Jacques et al., 1993; Zaza et al., 1996; Mangoni 
et al., 2003), and ryanodine receptor–dependent Ca
2+ 
Figure 8.  Recovery of resting heart rate in isolated WT and Girk4
/ hearts and time course of ACh-induced heart rate reduction 
under continuous ISO perfusion. (A, left) Basal heart rate (HR) recovery in 0.3 µM ACh after application of 0.1 µM ISO for 5 min 
in WT (n = 8; closed circles) and Girk4
/ (n = 7; open circles) Langendorff-perfused hearts. The first data point for each genotype 
represents heart rate under basal condition, whereas the second data point is the averaged maximal heart rate under ISO, before 
switching to the solution containing ACh. Dashed lines indicate the basal heart rate before ISO perfusion in WT (black) and Girk4
/ 
(gray) mice. Continuous lines represent fitting of experimental data points for calculating r of recovery. Averaged r for WT and 
Girk4
/ isolated hearts is shown in the insets. (right) Sample ECG traces from WT and Girk4
/ recorded in isolated hearts under 
resting conditions (before ISO) and 35 s after ACh application. Note that at 35 s in Girk4
/ but not in WT hearts, the pacing rate 
was still higher than at rest. (B) Similar to A, the first data point is the averaged maximal heart rate with ISO before perfusion. The 
time course (r) of rate reduction was calculated during combined perfusion of 0.1 µM ISO and ACh 0.3 µM after maximal stimula-
tion of pacing by ISO in WT (n = 8; closed circles) and Girk4
/ (n = 6; open circles) hearts. The inset shows averaged r for WT and 
Girk4
/ hearts. Error bars represent SEM. Statistical symbols: *, P < 0.05.124 IKACh ablation in sinoatrial node physiology
hormones. However, an additional possibility is that sym-
pathetic tone remains elevated after stress or forced physi-
cal activity for relatively long periods and that IKACh is an 
important mechanism to counteract this phenomenon.
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